Holdings of Sands Capital Alternatives, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 19 in 1 countries
- Top ten
- 87.6 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Klaviyo Inc | 3,649,678 | 71M $ | |
| 2 | SpyGlass Pharma Inc | 2,500,012 | 64.8M $ | |
| 3 | Beta Bionics Inc | 3,708,043 | 37.2M $ | |
| 4 | Inhibikase Therapeutics Inc | 13,018,965 | 21.9M $ | |
| 5 | Coupang Inc | 1,012,091 | 19.1M $ | |
| 6 | Samsara Inc | 560,287 | 17.8M $ | |
| 7 | DoorDash Inc | 111,231 | 16.7M $ | |
| 8 | BioAge Labs Inc | 786,353 | 13.8M $ | |
| 9 | 10X Genomics Inc | 481,770 | 10.2M $ | |
| 10 | Datadog Inc | 85,793 | 10.1M $ | |
| 11 | Acumen Pharmaceuticals Inc | 3,720,105 | 8.8M $ | |
| 12 | Toast Inc | 301,647 | 8M $ | |
| 13 | TARSUS PHARMACEUTICALS INC | 85,000 | 6M $ | |
| 14 | ServiceTitan Inc | 89,856 | 5.7M $ | |
| 15 | Taysha Gene Therapies Inc | 724,873 | 3.2M $ | |
| 16 | Snowflake Inc | 20,253 | 3.1M $ | |
| 17 | ACRIVON THERAPEUTICS INC | 2,122,605 | 3M $ | |
| 18 | Candel Therapeutics Inc | 405,837 | 2M $ | |
| 19 | FIGMA INC | 18,286 | 386.6K $ |
Sector breakdown
- Consumer discretionary 5.2 %
- Technology 4.1 %
- Unattributed 90.7 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 100.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 19 | 322.6M $ | 100.00 % |
Cite this page
Titelia. "Holdings of Sands Capital Alternatives, LLC". https://titelia.com/en/funds/US13F1846444